BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6639045)

  • 21. The action of cobra venom phospholipase A2 isoenzymes towards intact human erythrocytes.
    Roelofsen B; Trip MS; Verheij HM; Zevenbergen JL
    Biochim Biophys Acta; 1980 Aug; 600(3):1012-7. PubMed ID: 7407131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Purified phospholipase A2 from sheep erythrocyte membrane. Preferential hydrolysis according to polar groups and 2-acyl chains.
    Jimeno-Abendano J; Zahler P
    Biochim Biophys Acta; 1979 May; 573(2):266-75. PubMed ID: 444550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A possible mechanism of increased sodium influx in red cells with abnormal membrane lipid levels induced by phospholipase A2.
    Hashimoto M; Yawata Y
    Am J Hematol; 1987 Sep; 26(1):17-26. PubMed ID: 3631062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exploring the action and specificity of cobra venom phospholipase A2 toward human erythrocytes, ghost membranes, and lipid mixtures.
    Adamich M; Dennis EA
    J Biol Chem; 1978 Jul; 253(14):5121-5. PubMed ID: 670181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phospholipase A2 activity in resting and activated human neutrophils. Substrate specificity, pH dependence, and subcellular localization.
    Balsinde J; Diez E; Schüller A; Mollinedo F
    J Biol Chem; 1988 Feb; 263(4):1929-36. PubMed ID: 3123482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Turnover of the fatty acid moiety of complex lipids in blood cell membrane and its physiological significance--activation mechanism of platelet phospholipase A2].
    Kannagi R
    Seikagaku; 1987 Dec; 59(12):1291-307. PubMed ID: 3329667
    [No Abstract]   [Full Text] [Related]  

  • 27. Solubilization and properties of Ca2+-dependent human platelet phospholipase A2.
    Kramer RM; Checani GC; Deykin A; Pritzker CR; Deykin D
    Biochim Biophys Acta; 1986 Oct; 878(3):394-403. PubMed ID: 3756201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Marked increase of human platelet phospholipase A2 activity in vitro and demonstration of an endogenous inhibitor.
    Ballou LR; Cheung WY
    Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5203-7. PubMed ID: 6577416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isolation of a human myocardial cytosolic phospholipase A2 isoform. Fast atom bombardment mass spectroscopic and reverse-phase high pressure liquid chromatography identification of choline and ethanolamine glycerophospholipid substrates.
    Hazen SL; Hall CR; Ford DA; Gross RW
    J Clin Invest; 1993 Jun; 91(6):2513-22. PubMed ID: 8514863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of phospholipase A2 treatment of human erythrocyte membranes on the rates of spectrin-actin dissociation.
    Gottlieb MH
    Biochim Biophys Acta; 1982 Mar; 686(1):133-6. PubMed ID: 7066319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Purification of a 110-kilodalton cytosolic phospholipase A2 from the human monocytic cell line U937.
    Clark JD; Milona N; Knopf JL
    Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7708-12. PubMed ID: 2217203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acetylcholinesterase release from mammalian erythrocytes by phosphatidylinositol-specific phospholipase C of Bacillus thuringiensis and characterization of the released enzyme.
    Taguchi R; Suzuki K; Nakabayashi T; Ikezawa H
    J Biochem; 1984 Aug; 96(2):437-46. PubMed ID: 6501251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concanavalin A-induced increase in the membrane fluidity of chicken erythrocytes.
    Ito Y; Yoshimoto R; Irimura T; Setaka M; Shimizu H; Osawa T
    J Biochem; 1979 Dec; 86(6):1807-15. PubMed ID: 231035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Some aspects of rat platelet and serum phospholipase A2 activities.
    Aarsman AJ; Roosenboom CF; van Geffen GE; van den Bosch H
    Biochim Biophys Acta; 1985 Dec; 837(3):288-95. PubMed ID: 4063382
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Partial purification and properties of phospholipase A2 from rat liver mitochondria.
    Natori Y; Karasawa K; Arai H; Tamori-Natori Y; Nojima S
    J Biochem; 1983 Feb; 93(2):631-7. PubMed ID: 6841360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Properties of rabbit erythrocytes treated with phospholipase A2 from bee venom.
    Vaysse J; Pilardeau P; Garnier M
    Comp Biochem Physiol A Comp Physiol; 1986; 83(4):715-9. PubMed ID: 2870863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calcium regulation of phospholipase A2 is independent of calmodulin.
    Withnall MT; Brown TJ; Diocee BK
    Biochem Biophys Res Commun; 1984 Jun; 121(2):507-13. PubMed ID: 6732821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Localisation of phospholipase A2 and diglyceride lipase activities in human platelet intracellular membranes.
    Lagarde M; Menashi S; Crawford N
    FEBS Lett; 1981 Feb; 124(1):23-6. PubMed ID: 7215552
    [No Abstract]   [Full Text] [Related]  

  • 39. In vivo release and clearance of rat platelet phospholipase A2.
    Murakami M; Kudo I; Inoue K
    Biochim Biophys Acta; 1989 Oct; 1005(3):270-6. PubMed ID: 2804056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Purification and properties of a membrane-bound phospholipase A2 from rat ascites hepatoma 108A cells.
    Natori Y; Nishijima M; Nojima S; Satoh H
    J Biochem; 1980 Mar; 87(3):959-67. PubMed ID: 7390973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.